Since the involvement of epigenetics factors such as histone deacetylase in ACE2 expression has been indicated, there is a possibility of more effective treatment for COVID-19, for example, by combining HDAC inhibitors, which are already approved by the FDA, with Remdesivir or Dexamethasone. The gene discussed is HDAC9; the disease is COVID-19.